Patent US4642334A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4642334A Expired / Lapsed US ⏱️ 0.0 years remaining

Hybrid DNA prepared binding composition

Assignee: Merck Sharp & Dohme LLC
•
Filing: 1983-12-05
•
Granted: 1987-02-10
•
Expires: 2003-12-05
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Proteinaceous binding compositions are prepared employing hybrid DNA technology, where the variable region polypeptides of immunoglobulins are substantially reproduced to provide relatively small protein molecules having binding specificity and lacking the undesirable aspects of the heavy regions of immunoglobulins. The compositions find a wide range of use, particularly for physiological purposes for diagnosis and therapy. The binding compositions may be modified by labeling with radioisotopes, fluorescers, and toxins for specific applications in diagnosis or therapy.

Inventors

  • 👤 Kevin W. Moore
  • 👤 Alejandro Zaffaroni

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 13:01
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/531; A; A61; A61P; A61P37/00; C; C07; C07K; C07K16/00; C12; C12N; C12N15/00; C12N15/09; C12N15/10; A61K; A61K38/00; C07K2317/00; C07K2317/60; C07K2317/62; C07K2317/622; Y; Y10; Y10S; Y10S424/00; Y10S424/801; Y10S530/00; Y10S530/808; Y10S530/809; Y10S530/866; Y10S530/867; Y10S930/00; Y10S930/01; Y10S930/30

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 100 words
A specific binding composition ("rFv") comprising two polypeptide chains having substantially the same amino acid sequence of at least a portion of the variable region, without constant region amino acids, of a mammalian immunoglobulin, said immunoglobulin having binding specificity to a predetermined ligand, wherein said polypeptide chains are prepared by expression of a DNA sequence coding for the variable region, said expression occurring in the absence of expression of a DNA sequence coding for natively associated constant region, and wherein said two polypeptide chains combine to form the rFv which has a high affinity and specificity for said predetermined ligand.
Claim 2
Dependent Claim 100 words
A specific binding composition ("rFv") comprising two polypeptide chains having substantially the same amino acid sequence of at least a portion of the variable region, without constant region amino acids, of a mammalian immunoglobulin, said immunoglobulin having binding specificity to a predetermined ligand, wherein said polypeptide chains are prepared by expression of a DNA sequence coding for the variable region, said expression occurring in the absence of expression of a DNA sequence coding for natively associated constant region, and wherein said two polypeptide chains combine to form the rFv which has a high affinity and specificity for said predetermined ligand.
Claim 3
Dependent Claim 43 words
A composition according to claim 1, wherein said two polypeptide chains are the light chain of from about 95 to 115 amino acids and the heavy chain of from about 110 to 125 amino acids, wherein said heavy chain includes the D region.
Claim 4
Dependent Claim 37 words
A composition according to any one of claims 1 or 2, wherein each of said chains includes at least two cysteines separated by from about 60 to 70 amino acids and joined together through a disulfide link.
Claim 5
Dependent Claim 25 words
A composition according to any one of claims 1 or 2 wherein said rFv is labeled with a functionality capable of producing a detectable signal.
Claim 6
Dependent Claim 20 words
A composition according to any one of claims 1 or 2 wherein said rFv is labeled with a cytotoxic agent.
Claim 7
Dependent Claim 13 words
A composition according to claim 5, wherein said cytotoxic agent is a radionuclide.

References Cited (Backward Citations)

US4237224A Cited
US4283489A Cited
US4332892A Cited
US4293652A Cited
US4262090A Cited
US4355023A Cited
US4470925A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-02-09 1990-08-11 1991-02-10 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-02-09 1994-08-11 1995-02-10 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-02-09 1998-08-11 1999-02-10 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag